Despite not reaching statistical significance, there is a larger number of adenocarcinoma (ADC) exhibiting NY-ESO-1 promoter hypermethylation when compared to that of squamous cell carcinoma (SCC). The gene discussed is CTAG1B; the disease is adenocarcinoma.